help button home button Biophys. J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Biophys. J. BioFAST: First Published March 11, 2005. doi:10.1529/biophysj.104.050286
© 2005 by the Biophysical Society.


A more recent version of this article appeared on May 1, 2005.
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
biophysj.104.050286v1
88/5/3072    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brigo, A.
Right arrow Articles by Briggs, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brigo, A.
Right arrow Articles by Briggs, J. M.

BIOPHYSICAL THEORY AND MODELING

Comparison of Multiple Molecular Dynamics Trajectories Calculated for the Drug-Resistant HIV-1 Integrase T66I/M154I Catalytic Domain

Alessandro Brigo 1, Keun Woo Lee 2, Gabriela Iurcu Mustata 3 and James M. Briggs 2*

1 The Genetics Company
2 University of Houston
3 Emisphere Technologies, Inc.

* To whom correspondence should be addressed. E-mail: jbriggs{at}uh.edu.

Submitted on July 22, 2004
Revised on August 24, 2004
Accepted on 21 December 2004


   Abstract
HIV-1 integrase (IN) is an essential enzyme for the viral replication and an interesting target for the design of new pharmaceuticals for multi-drug therapy of AIDS. Single and multiple mutations of IN at residues T66, S153 or M154 confer degrees of resistance to several inhibitors that prevent the enzyme from performing its normal strand transfer activity. Four different conformations of IN were chosen from a prior molecular dynamics (MD) simulation on the modeled IN T66I/M154I catalytic core domain as starting points for additional MD studies. The aim of this paper is to understand the dynamic features that may play roles in the catalytic activity of the double mutant enzyme in the absence of any inhibitor. Moreover, we want to verify the influence of using different starting points on the MD trajectories and associated dynamical properties. By comparison of the trajectories obtained from these MD simulations we have demonstrated that the starting point does not affect the conformational space explored by this protein and that the time of the simulation is long enough to achieve convergence for this system.

Key Words: conformational sampling, drug resistance, essential dynamics, molecular dynamics




This article has been cited by other articles:


Home page
Biophys. JHome page
C. N. Alves, S. Marti, R. Castillo, J. Andres, V. Moliner, I. Tunon, and E. Silla
A Quantum Mechanic/Molecular Mechanic Study of the Wild-Type and N155S Mutant HIV-1 Integrase Complexed with Diketo Acid
Biophys. J., April 1, 2008; 94(7): 2443 - 2451.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
N. Nunthaboot, S. Pianwanit, V. Parasuk, J. O. Ebalunode, J. M. Briggs, and S. Kokpol
Hybrid Quantum Mechanical/Molecular Mechanical Molecular Dynamics Simulations of HIV-1 Integrase/Inhibitor Complexes
Biophys. J., November 15, 2007; 93(10): 3613 - 3626.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2005 by the Biophysical Society.